{"created":"2024-11-29T05:20:34.019685+00:00","id":2001716,"links":{},"metadata":{"_buckets":{"deposit":"26f5f9d3-b87a-48ad-aa06-e6700982fbf0"},"_deposit":{"created_by":8,"id":"2001716","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2001716"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02001716","sets":["1732778801467:1732778962699:1732856458937"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Satoh, Koichiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takano, Shizuko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Onogi, Takashi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ohtsuki, Koji","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kobayashi, Toshio","creatorNameLang":"en"}]}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2006 The Fukushima Society of Medical Science","subitem_rights_language":"en"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"Fluvoxamine","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Paroxetine","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Serotonin syndrome","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Spinal cord injury","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Adolescent","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Antidepressive Agents, Second-Generation","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Fluvoxamine","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Humans","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Male","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Paroxetine","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Serotonin Syndrome","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Serotonin Uptake Inhibitors","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Spinal Cord Injuries","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"There have been only a few reports of serotonin syndrome developing after mono-therapy with a selective serotonin reuptake inhibitor (SSRI). We report a case of serotonin syndrome caused by long-term therapy with fluvoxamine prior to treatment with paroxetine. An 18-year-old man with spinal cord injury (SCI) at thoracic level 2-3 presented with onset of serotonin syndrome after taking fluvoxamine (50 mg per day) for 8 weeks prior to treatment with paroxetine (10 mg per day) for 6 days. He had confusion, agitation, severe headache, tachycardia (124 beats/minute), hypertension (165/118 mmHg), high fever (39.1 degrees C), and myoclonus. All of the symptoms disappeared within 24 hours after discontinuation of administration of paroxetine. This is an interesting case of serotonin syndrome that developed after minimum doses of single therapy with an SSRI in a patient with SCI.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"The Fukushima Society of Medical Science","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"0016-2590","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2185-4610","subitem_source_identifier_type":"EISSN"},{"subitem_source_identifier":"AA0065246X","subitem_source_identifier_type":"NCID"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2006-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"33","bibliographicPageStart":"29","bibliographicVolumeNumber":"52","bibliographic_titles":[{"bibliographic_title":"Fukushima Journal of Medical Science","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5387/fms.52.29","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"16995352","subitem_relation_type_select":"PMID"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"2007106570","subitem_relation_type_select":"ICHUSHI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2011-05-26"}],"displaytype":"detail","filename":"FksmJMedSci_52_p29.pdf","filesize":[{"value":"573.1 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://fmu.repo.nii.ac.jp/record/2001716/files/FksmJMedSci_52_p29.pdf"},"version_id":"e0ae1e8c-85c9-4ae8-9aae-72dbb5442a5a"}]},"item_title":"Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury","item_type_id":"40002","owner":"8","path":["1732856458937"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2011-05-26"},"publish_date":"2011-05-26","publish_status":"0","recid":"2001716","relation_version_is_last":true,"title":["Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2024-11-29T05:33:57.249582+00:00"}